163 related articles for article (PubMed ID: 22588557)
1. A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression.
Oikawa K; Tanaka M; Itoh S; Takanashi M; Ozaki T; Muragaki Y; Kuroda M
Br J Cancer; 2012 Jun; 106(12):1976-9. PubMed ID: 22588557
[TBL] [Abstract][Full Text] [Related]
2. TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma.
Borjigin N; Ohno S; Wu W; Tanaka M; Suzuki R; Fujita K; Takanashi M; Oikawa K; Goto T; Motoi T; Kosaka T; Yamamoto K; Kuroda M
Biochem Biophys Res Commun; 2012 Oct; 427(2):355-60. PubMed ID: 22995304
[TBL] [Abstract][Full Text] [Related]
3. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.
Andersson MK; Göransson M; Olofsson A; Andersson C; Aman P
BMC Cancer; 2010 Jun; 10():249. PubMed ID: 20515481
[TBL] [Abstract][Full Text] [Related]
4. DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2.
Bento C; Andersson MK; Aman P
BMC Cell Biol; 2009 Dec; 10():89. PubMed ID: 20017906
[TBL] [Abstract][Full Text] [Related]
5. Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: a comparative ultrastructural and RT-PCR analysis of 14 cases of myxoid/round cell liposarcomas.
Huang HY; Antonescu CR
Ultrastruct Pathol; 2003; 27(4):217-26. PubMed ID: 12907366
[TBL] [Abstract][Full Text] [Related]
6. Role of FUS-CHOP in Myxoid Liposarcoma via miR-486/CDK4 Axis.
Wu H; Xia L; Xu H
Biochem Genet; 2022 Jun; 60(3):1095-1106. PubMed ID: 34792704
[TBL] [Abstract][Full Text] [Related]
7. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.
Tornin J; Hermida-Prado F; Padda RS; Gonzalez MV; Alvarez-Fernandez C; Rey V; Martinez-Cruzado L; Estupiñan O; Menendez ST; Fernandez-Nevado L; Astudillo A; Rodrigo JP; Lucien F; Kim Y; Leong HS; Garcia-Pedrero JM; Rodriguez R
Neoplasia; 2018 Jan; 20(1):44-56. PubMed ID: 29190494
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development.
Ranji P; Jonasson E; Andersson L; Filges S; Luna Santamaría M; Vannas C; Dolatabadi S; Gustafsson A; Myklebost O; Håkansson J; Fagman H; Landberg G; Åman P; Ståhlberg A
J Transl Med; 2024 Apr; 22(1):389. PubMed ID: 38671504
[TBL] [Abstract][Full Text] [Related]
10. PRG4 expression in myxoid liposarcoma maintains tumor cell growth through suppression of an antitumor cytokine IL-24.
Oikawa K; Mizusaki A; Takanashi M; Ozaki T; Sato F; Kuroda M; Muragaki Y
Biochem Biophys Res Commun; 2017 Mar; 485(1):209-214. PubMed ID: 28192118
[TBL] [Abstract][Full Text] [Related]
11. Induction of a secreted protein by the myxoid liposarcoma oncogene.
Kuroda M; Wang X; Sok J; Yin Y; Chung P; Giannotti JW; Jacobs KA; Fitz LJ; Murtha-Riel P; Turner KJ; Ron D
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5025-30. PubMed ID: 10220412
[TBL] [Abstract][Full Text] [Related]
12. The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.
Engström K; Willén H; Kåbjörn-Gustafsson C; Andersson C; Olsson M; Göransson M; Järnum S; Olofsson A; Warnhammar E; Aman P
Am J Pathol; 2006 May; 168(5):1642-53. PubMed ID: 16651630
[TBL] [Abstract][Full Text] [Related]
13. Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation.
Rodriguez R; Tornin J; Suarez C; Astudillo A; Rubio R; Yauk C; Williams A; Rosu-Myles M; Funes JM; Boshoff C; Menendez P
Stem Cells; 2013 Oct; 31(10):2061-72. PubMed ID: 23836491
[TBL] [Abstract][Full Text] [Related]
14. Generation of the novel monoclonal antibody against TLS/EWS-CHOP chimeric oncoproteins that is applicable to one of the most sensitive assays for myxoid and round cell liposarcomas.
Oikawa K; Ishida T; Imamura T; Yoshida K; Takanashi M; Hattori H; Ishikawa A; Fujita K; Yamamoto K; Matsubayashi J; Kuroda M; Mukai K
Am J Surg Pathol; 2006 Mar; 30(3):351-6. PubMed ID: 16538055
[TBL] [Abstract][Full Text] [Related]
15. Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.
Rivero ER; Mesquita RA; de Sousa SC; Nunes FD
Ann Diagn Pathol; 2006 Feb; 10(1):36-8. PubMed ID: 16414544
[TBL] [Abstract][Full Text] [Related]
16. The myxoid liposarcoma specific TLS-CHOP fusion protein localizes to nuclear structures distinct from PML nuclear bodies.
Thelin-Järnum S; Göransson M; Burguete AS; Olofsson A; Aman P
Int J Cancer; 2002 Feb; 97(4):446-50. PubMed ID: 11802205
[TBL] [Abstract][Full Text] [Related]
17. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
Göransson M; Andersson MK; Forni C; Ståhlberg A; Andersson C; Olofsson A; Mantovani R; Aman P
Oncogene; 2009 Jan; 28(2):270-8. PubMed ID: 18850010
[TBL] [Abstract][Full Text] [Related]
18. Myxoid liposarcoma with cartilaginous differentiation: identification of the same type II TLS-CHOP fusion gene transcript in both lipogenic and chondroid components.
Wei YC; Li CF; Eng HL; Yeh MC; Lin CN; Huang HY
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):477-80. PubMed ID: 18091394
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
Uboldi S; Bernasconi S; Romano M; Marchini S; Fuso Nerini I; Damia G; Ganzinelli M; Marangon E; Sala F; Clivio L; Chiorino G; Di Giandomenico S; Rocchi M; Capozzi O; Margison GP; Watson AJ; Caccuri AM; Pastore A; Fossati A; Mantovani R; Grosso F; Tercero JC; Erba E; D'Incalci M
Int J Cancer; 2012 Jul; 131(1):59-69. PubMed ID: 21805478
[TBL] [Abstract][Full Text] [Related]
20. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
